ArticleTherapeutics and clinical risk management2020

Outcomes of Adding Induction Chemotherapy to Concurrent Chemotherapy for Nasopharyngeal Carcinoma Patients with Moderate-Risk in the Intensity-Modulated Radiotherapy Era.

Zhen Su et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.